Hytrin 1mg 1 Tablet
₱80.50
IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.
An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.
| Brand Name | HYTRIN 1MG |
| Generic Name | Terazosin (as Hydrochloride) |
| Strength | 1 mg Terazosin (as Hydrochloride) |
| Dosage Form | Tablet |
| Class Name | Alpha-adrenoceptor antagonist |
| Indication/Usage | Terazosin hydrochloride used alone or in combination with other antihypertensive agents is indicated for the treatment of hypertension. Terazosin hydrochloride single therapy is also used to relieve the signs and symptoms of benign prostatic hyperplasia (BPH). |
| Dosage and Administration | The dose of terazosin (as hydrochloride) should be adjusted according to the patient's individual response. The following is a guide to its administration: Initial Dose The recommended starting dose for all patients is 1 mg at bedtime. This dose should not be exceeded. This initial dosing regimen should be strictly observed to minimize the potential for severe hypotensive effects. Subsequent Doses Hypertension The dose may be slowly increased to achieve the desired blood pressure response. The usual recommended dose range is 1 to 5 mg administered once a day; however, some patients may benefit from doses as high as 20 mg per day. Doses over 20 mg do not appear to provide further blood pressure effect and doses over 40 mg have not been studied. Blood pressure should be monitored at the end of the dosing interval to be sure control is maintained throughout the interval. It may also be helpful to measure blood pressure 2 to 3 hours after dosing to see if the maximum and minimum responses are similar, and to evaluate symptoms such as dizziness or palpitations which can result from excessive hypotensive response. If response is substantially diminished at 24 hours, an increased dose or use of a twice daily regimen can be considered. If terazosin (as hydrochloride) administration is discontinued for several days or longer, therapy should be reinstituted using the initial dosing regimen. In clinical trials, except for the initial dose, the dose was given in the morning. Benign Prostatic Hyperplasia (BPH) The dose may be slowly increased to achieve the desired clinical response in BPH patients. The usual recommended dose range is 5 to10 mg administered once a day. Urine flow rate measured approximately 24 hours after the last dose has shown the beneficial effect in BPH persists for the recommended dosing interval. Symptom improvements have been detected as early as two weeks after starting treatment with terazosin (as hydrochloride). Improvements on flow rate may be seen somewhat later. If terazosin (as hydrochloride) administration is discontinued for several days or longer, therapy should be reinstituted using the initial dosing regimen. |
| Warning and Precautions | - Syncope and "First-dose" effect - Orthostatic hypotension - Hypotension has been reported when terazosin has been used with phosphodiesterase-5 (PDE5) inhibitors (see section 4.5 Interaction with other medicinal products and other forms of interaction). - Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients on/or previously treated with alpha-1 blockers. - Small but statistically significant decreases in hematocrit, hemoglobin, white blood cells, total protein and albumin were observed in controlled clinical trials. These laboratory findings suggested the possibility of hemodilution. Treatment with terazosin (as hydrochloride) for up to 24 months had no significant effect on prostate specific antigen (PSA) levels. |
| Contraindication | Terazosin (as hydrochloride) is contraindicated in patients known to be hypersensitive to terazosin (as hydrochloride) or its analogues. |
| Requires prescription? | Yes |
| Storage Conditions | Store at temperatures not exceeding 30°C, away from direct heat and sunlight |
| Manufacturer | Aesica Queenborough Limited |
| Regulatory Classification | Prescription Drug |
Related Products
Hytrin 2mg 1 Tablet
₱106.50
IMPORTANT NOTICE:For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp,...
